Premium
Executive summary of the SCAI/HFSA clinical expert consensus document on the use of invasive hemodynamics for the diagnosis and management of cardiovascular disease
Author(s) -
Sorajja Paul,
Borlaug Barry A.,
Dimas Vivian,
Fang James C.,
Forfia Paul R.,
Givertz Michael M.,
Kapur Navin K.,
Kern Morton J.,
Naidu Srihari S.
Publication year - 2017
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.27036
Subject(s) - medicine , executive summary , hemodynamics , appropriate use criteria , disease , intensive care medicine , cardiology , disease management , medline , microbiology and biotechnology , biology , parkinson's disease , political science , law
Modern insight into cardiovascular pathophysiology first emerged through detailed invasive hemodynamic studies performed in the cardiac catheterization laboratory. Understanding the evolution of these concepts and their clinical utility remain fundamental to practice. Although noninvasive methods are now routinely used, invasive catheterbased assessments remain the gold standard for hemodynamic evaluation of cardiovascular disease. On behalf of the Heart Failure Society of America (HFSA) and the Society for Cardiovascular Angiography and Interventions (SCAI), we recently published a consensus document on this topic [1]. We defined clinically relevant hemodynamic concepts and their invasive assessment; described clinical scenarios in which invasive hemodynamics should be strongly considered; and emphasized the need for maintenance of quality and continuous professional development. Below is an executive summary of this document that highlights clinical scenarios and recommendations, and in particular those that involve the management of patients with heart failure.